Gene · 722
Papers2,921
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,921
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current status and progress in research on dressing management for diabetic foot ulcer. | Front Endocrinol (Lausanne) | 2023 | 37664860 | PubTator, text mining | PubMed |
| Immune responses to Neisseria gonorrhoeae and implications for vaccine development. | Front Immunol | 2023 | 37662926 | PubTator, text mining | PubMed |
| L-serine combined with carboxymethyl chitosan guides amorphous calcium phosphate to remineralize enamel. | J Mater Sci Mater Med | 2023 | 37658964 | PubTator, text mining | PubMed |
| Corticosteroids in COVID-19: pros and cons. | Front Med (Lausanne) | 2023 | 37644981 | PubTator, text mining | PubMed |
| Current Knowledge and Future Perspectives of Exosomes as Nanocarriers in Diagnosis and Treatment of Diseases. | Int J Nanomedicine | 2023 | 37635911 | PubTator, text mining | PubMed |
| A Review: The Potential Involvement of Growth Arrest-Specific 6 and Its Receptors in the Pathogenesis of Lung Damage and in Coronavirus Disease 2019. | Microorganisms | 2023 | 37630598 | PubTator, text mining | PubMed |
| Ultrasensitive Electrochemical Immunosensors Using Nanobodies as Biocompatible Sniffer Tools of Agricultural Contaminants and Human Disease Biomarkers. | Micromachines (Basel) | 2023 | 37630022 | PubTator, text mining | PubMed |
| Complement System Activation Is a Plasma Biomarker Signature during Malaria in Pregnancy. | Genes (Basel) | 2023 | 37628675 | PubTator, text mining | PubMed |
| Intraarticular management of chronic haemophilic arthropathy (Review). | Biomed Rep | 2023 | 37614987 | PubTator, text mining | PubMed |
| Mirikizumab-Induced Transcriptome Changes in Ulcerative Colitis Patient Biopsies at Week 12 Are Maintained Through Week 52. | Clin Transl Gastroenterol | 2023 | 37594044 | PubTator, text mining | PubMed |
| Reanalysis of Single-Cell RNA-Sequencing Data in Patients with COVID-19: Insights and Limitations. | Am J Respir Cell Mol Biol | 2023 | 37590905 | PubTator, text mining | PubMed |
| The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications. | J Mol Med (Berl) | 2023 | 37584739 | PubTator, text mining | PubMed |
| Coronavirus Disease Pathophysiology: Biomarkers, Potential New Remedies, Comorbidities, Long COVID-19, Post Pandemic Epidemiological Surveillance. | Int J Mol Sci | 2023 | 37569612 | PubTator, text mining | PubMed |
| PepO and CppA modulate Streptococcus sanguinis susceptibility to complement immunity and virulence. | Virulence | 2023 | 37563831 | PubTator, text mining | PubMed |
| Platelet-rich plasma in the pathologic processes of tendinopathy: a review of basic science studies. | Front Bioeng Biotechnol | 2023 | 37545895 | PubTator, text mining | PubMed |
| Secretory pathways and multiple functions of nonstructural protein 1 in flavivirus infection. | Front Immunol | 2023 | 37520540 | PubTator, text mining | PubMed |
| mTOR Inhibition via Low-Dose, Pulsed Rapamycin with Intraovarian Condensed Platelet Cytokines: An Individualized Protocol to Recover Diminished Reserve? | J Pers Med | 2023 | 37511761 | PubTator, text mining | PubMed |
| The Contribution of Vascular Proteoglycans to Atherothrombosis: Clinical Implications. | Int J Mol Sci | 2023 | 37511615 | PubTator, text mining | PubMed |
| Exploring the Potential of Aptamers in Targeting Neuroinflammation and Neurodegenerative Disorders: Opportunities and Challenges. | Int J Mol Sci | 2023 | 37511539 | PubTator, text mining | PubMed |
| Spatially Resolved Proteomic and Transcriptomic Profiling of Anaplastic Lymphoma Kinase-Rearranged Pulmonary Adenocarcinomas Reveals Key Players in Inter- and Intratumoral Heterogeneity. | Int J Mol Sci | 2023 | 37511126 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/722/papers?page=11